Revenue $5.51B, up 7.2% on a year earlier. Sales of Products $3.60B, up 6.7%. Sales of Services $1.91B, up 8.0%. Diluted EPS $1.36 against $0.98.
| Q3 FY26 | Q2 FY26 | Q3 FY25 | Year over year | |
|---|---|---|---|---|
| Revenue | $5.51B | $5.29B | $5.14B | +7.2% |
| Operating income | $805.00M | $739.00M | $653.00M | +23.3% |
| Net income | $615.00M | $561.00M | $446.00M | +37.9% |
| Diluted EPS | $1.36 | $1.24 | $0.98 | |
| Operating cash flow | $907.00M | $168.00M | $593.00M | +53.0% |
| Capital expenditures | -$114.00M | -$100.00M | -$110.00M | |
| Free cash flow | $793.00M | $68.00M | $483.00M | +64.2% |
| Dividend per share | $0.04 | $0.04 | $0.04 |
| Q3 FY26 | Q3 FY25 | Year over year | |
|---|---|---|---|
| Sales of Products | $3.60B | $3.38B | +6.7% |
| Sales of Services | $1.91B | $1.77B | +8.0% |
| Imaging segment revenues | $2.46B | $2.35B | +4.9% |
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “GE HealthCare Technologies (GEHC) Q3 FY26 earnings: results and KPIs”, stockatlas.com/companies/GEHC/earnings/2026-q3/, data as of 3 November 2026. Links to this page are welcome.
